Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer

Correlation between serum squamous cell carcinoma antigen level and tumor volume in Head and Neck Cancer is to determine a correlation between level of serum squamous cell carcinoma antigen and tumor volume in Head and Neck Caner measured by cross-sectional imaging.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Head and Neck Cancer Head and Neck Neoplasms Neoplasms Neoplasms by Site

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of Medicine, Prince of Songkla University

Hadyai, Changwat Songkhla, 90110, Thailand

About this study

The study is a cross-sectional study. A single measurement of serum squamous cell carcinoma antigen level is performed in the eligible Head and Neck squamous cell carcinoma patients.

The study tool measuring serum squamous cell carcinoma antigen level is ARCHITECT SCC (Abbott).

The gross tumor volume in the cross sectional imaging obtained within 2 weeks of each patient is calculated with the typical ellipsoid formula.

Correlation between both parameters will be determined.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Histologically proven squamous cell carcinoma in Head and Neck
Getting a cross-sectional imaging of Head and Neck within 2 weeks of collecting serum squamous cell carcinoma antigen

Exclusion criteria

Metastatic disease
Accompanied Non-Head and Neck squamous cell carcinoma
Nasopharyngeal, thyroid, salivary, nose and paranasal sinus carcinoma
Skin disease: eczema, erythrodermic epidermitis, pemphigus, and psoriasis
Pulmonary disease: tuberculosis, adult respiratory distress syndrome, pulmonary infiltration with eosinophilia, sarcoidosis, and bronchogenic cyst
Renal failure
Using antihistamine eye drops

Treatment and study plan

Non-Interventional Study

Other

Primary outcomes

Correlation between serum squamous cell carcinoma antigen and tumor volume

Time frame: 2 weeks

Sponsors and collaborators

Lead sponsor

Prince of Songkla University

Other

Registry information

Official study title

Correlation Between Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer

Important dates

Study start: 2016
Primary completion: 2018
Study completion: 2018
First posted: Aug 26, 2016
Registry last updated: Mar 4, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed